Neogen Corporation Payments to Acquire Marketable Securities
Neogen Corporation (NEOG) reported Payments to Acquire Marketable Securities of $0 for the 12-month period ending 2025-05-31, per its 10-K filed 2025-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2025-07-30
- Neogen Corporation payments to acquire marketable securities for the quarter ending 2024-05-31 was $0.00.
- Neogen Corporation payments to acquire marketable securities for the quarter ending 2024-02-29 was $0.00.
- Neogen Corporation payments to acquire marketable securities for the quarter ending 2023-11-30 was $0.00.
- Neogen Corporation payments to acquire marketable securities for the quarter ending 2023-08-31 was $0.00, a 100.00% decline year-over-year.
- Neogen Corporation payments to acquire marketable securities for fiscal 2025 was $0.00.
- Neogen Corporation payments to acquire marketable securities for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Neogen Corporation payments to acquire marketable securities for fiscal 2023 was $12.52M, a 96.99% decline from fiscal 2022.
- Neogen Corporation payments to acquire marketable securities for fiscal 2022 was $415.89M, a 47.53% decline from fiscal 2021.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2025-05-31 | $0.00 10-K · filed 2025-07-30 | |||
| 2024-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | $0.00 derived: sum of 2 quarters · filed 2025-07-30 | $0.00 derived: sum of 3 quarters · filed 2025-07-30 | $0.00 10-K · filed 2025-07-30 |
| 2024-02-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | $0.00 derived: sum of 2 quarters · filed 2024-04-09 | $0.00 10-Q · filed 2024-04-09 | $0.00 derived: sum of 4 quarters · filed 2025-07-30 |
| 2023-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | $0.00 10-Q · filed 2024-01-09 | $0.00 derived: sum of 3 quarters · filed 2025-07-30 | $0.00 derived: sum of 4 quarters · filed 2025-07-30 |
| 2023-08-31 | $0.00 10-Q · filed 2023-10-10 | $0.00 derived: sum of 2 quarters · filed 2025-07-30 | $0.00 derived: sum of 3 quarters · filed 2025-07-30 | $0.00 derived: sum of 4 quarters · filed 2025-07-30 |
| 2023-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | $0.00 derived: sum of 2 quarters · filed 2025-07-30 | $0.00 derived: sum of 3 quarters · filed 2025-07-30 | $12.52M 10-K · filed 2025-07-30 |
| 2023-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | $0.00 derived: sum of 2 quarters · filed 2024-04-09 | $12.52M 10-Q · filed 2024-04-09 | $113.97M derived: sum of 4 quarters · filed 2024-07-30 |
| 2022-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | $12.52M 10-Q · filed 2024-01-09 | $113.97M derived: sum of 3 quarters · filed 2024-07-30 | $197.83M derived: sum of 4 quarters · filed 2024-07-30 |
| 2022-08-31 | $12.52M 10-Q · filed 2023-10-10 | $113.97M derived: sum of 2 quarters · filed 2024-07-30 | $197.83M derived: sum of 3 quarters · filed 2024-07-30 | $291.67M derived: sum of 4 quarters · filed 2024-07-30 |
| 2022-05-31 | $101.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $185.31M derived: sum of 2 quarters · filed 2024-07-30 | $279.15M derived: sum of 3 quarters · filed 2024-07-30 | $415.89M 10-K · filed 2024-07-30 |
| 2022-02-28 | $83.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-04 | $177.69M derived: sum of 2 quarters · filed 2023-04-04 | $314.44M 10-Q · filed 2023-04-04 | $502.43M derived: sum of 4 quarters · filed 2023-08-15 |
| 2021-11-30 | $93.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | $230.59M 10-Q · filed 2023-01-09 | $418.57M derived: sum of 3 quarters · filed 2023-08-15 | $714.74M derived: sum of 4 quarters · filed 2023-08-15 |
| 2021-08-31 | $136.75M 10-Q · filed 2022-09-30 | $324.73M derived: sum of 2 quarters · filed 2023-08-15 | $620.90M derived: sum of 3 quarters · filed 2023-08-15 | $761.11M derived: sum of 4 quarters · filed 2023-08-15 |
| 2021-05-31 | $187.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-15 | $484.15M derived: sum of 2 quarters · filed 2023-08-15 | $624.36M derived: sum of 3 quarters · filed 2023-08-15 | $792.68M 10-K · filed 2023-08-15 |
| 2021-02-28 | $296.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-01 | $436.38M derived: sum of 2 quarters · filed 2022-04-01 | $604.69M 10-Q · filed 2022-04-01 | $711.99M derived: sum of 4 quarters · filed 2022-07-27 |
| 2020-11-30 | $140.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-30 | $308.52M 10-Q · filed 2021-12-30 | $415.82M derived: sum of 3 quarters · filed 2022-07-27 | $546.30M derived: sum of 4 quarters · filed 2022-07-27 |
| 2020-08-31 | $168.32M 10-Q · filed 2021-09-30 | $275.62M derived: sum of 2 quarters · filed 2022-07-27 | $406.09M derived: sum of 3 quarters · filed 2022-07-27 | $523.19M derived: sum of 4 quarters · filed 2022-07-27 |
| 2020-05-31 | $107.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27 | $237.77M derived: sum of 2 quarters · filed 2022-07-27 | $354.87M derived: sum of 3 quarters · filed 2022-07-27 | $458.30M 10-K · filed 2022-07-27 |
| 2020-02-29 | $130.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-31 | $247.57M derived: sum of 2 quarters · filed 2021-03-31 | $351.00M 10-Q · filed 2021-03-31 | $472.13M derived: sum of 4 quarters · filed 2021-07-30 |
| 2019-11-30 | $117.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-29 | $220.53M 10-Q · filed 2020-12-29 | $341.66M derived: sum of 3 quarters · filed 2021-07-30 | $466.36M derived: sum of 4 quarters · filed 2021-07-30 |
| 2019-08-31 | $103.43M 10-Q · filed 2020-09-30 | $224.56M derived: sum of 2 quarters · filed 2021-07-30 | $349.27M derived: sum of 3 quarters · filed 2021-07-30 | $466.21M derived: sum of 4 quarters · filed 2021-07-30 |
| 2019-05-31 | $121.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-30 | $245.84M derived: sum of 2 quarters · filed 2021-07-30 | $362.77M derived: sum of 3 quarters · filed 2021-07-30 | $437.32M 10-K · filed 2021-07-30 |
| 2019-02-28 | $124.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | $241.65M derived: sum of 2 quarters · filed 2020-04-03 | $316.19M 10-Q · filed 2020-04-03 | $422.27M derived: sum of 4 quarters · filed 2020-07-30 |
| 2018-11-30 | $116.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-27 | $191.49M 10-Q · filed 2019-12-27 | $297.56M derived: sum of 3 quarters · filed 2020-07-30 | $383.96M derived: sum of 4 quarters · filed 2020-07-30 |
| 2018-08-31 | $74.55M 10-Q · filed 2019-09-26 | $180.62M derived: sum of 2 quarters · filed 2020-07-30 | $267.02M derived: sum of 3 quarters · filed 2020-07-30 | $356.00M derived: sum of 4 quarters · filed 2020-07-30 |
| 2018-05-31 | $106.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30 | $192.48M derived: sum of 2 quarters · filed 2020-07-30 | $281.45M derived: sum of 3 quarters · filed 2020-07-30 | $361.42M 10-K · filed 2020-07-30 |
| 2018-02-28 | $86.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-29 | $175.38M derived: sum of 2 quarters · filed 2019-03-29 | $255.35M 10-Q · filed 2019-03-29 | $302.99M derived: sum of 4 quarters · filed 2019-07-30 |
| 2017-11-30 | $88.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-28 | $168.94M 10-Q · filed 2018-12-28 | $216.58M derived: sum of 3 quarters · filed 2019-07-30 | $263.91M derived: sum of 4 quarters · filed 2019-07-30 |
| 2017-08-31 | $79.97M 10-Q · filed 2018-10-05 | $127.61M derived: sum of 2 quarters · filed 2019-07-30 | $174.93M derived: sum of 3 quarters · filed 2019-07-30 | $214.11M derived: sum of 4 quarters · filed 2019-07-30 |
| 2017-05-31 | $47.64M derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-30 | $94.96M derived: sum of 2 quarters · filed 2019-07-30 | $134.14M derived: sum of 3 quarters · filed 2019-07-30 | $162.75M 10-K · filed 2019-07-30 |
| 2017-02-28 | $47.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-29 | $86.50M derived: sum of 2 quarters · filed 2018-03-29 | $115.12M 10-Q · filed 2018-03-29 | $143.48M derived: sum of 4 quarters · filed 2018-07-27 |
| 2016-11-30 | $39.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | $67.79M 10-Q · filed 2018-01-05 | $96.16M derived: sum of 3 quarters · filed 2018-07-27 | $135.50M derived: sum of 4 quarters · filed 2018-07-27 |
| 2016-08-31 | $28.62M 10-Q · filed 2017-09-29 | $56.98M derived: sum of 2 quarters · filed 2018-07-27 | $96.33M derived: sum of 3 quarters · filed 2018-07-27 | $131.07M derived: sum of 4 quarters · filed 2018-07-27 |
| 2016-05-31 | $28.36M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-27 | $67.71M derived: sum of 2 quarters · filed 2018-07-27 | $102.45M derived: sum of 3 quarters · filed 2018-07-27 | $151.63M 10-K · filed 2018-07-27 |
| 2016-02-29 | $39.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-31 | $74.09M derived: sum of 2 quarters · filed 2017-03-31 | $123.26M 10-Q · filed 2017-03-31 | $152.94M derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-11-30 | $34.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-29 | $83.92M 10-Q · filed 2016-12-29 | $113.60M derived: sum of 3 quarters · filed 2017-07-28 | $138.09M derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-08-31 | $49.17M 10-Q · filed 2016-09-30 | $78.86M derived: sum of 2 quarters · filed 2017-07-28 | $103.35M derived: sum of 3 quarters · filed 2017-07-28 | $133.35M derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-05-31 | $29.68M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $54.18M derived: sum of 2 quarters · filed 2017-07-28 | $84.18M derived: sum of 3 quarters · filed 2017-07-28 | $105.94M 10-K · filed 2017-07-28 |
| 2015-02-28 | $24.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-31 | $54.50M derived: sum of 2 quarters · filed 2016-03-31 | $76.26M 10-Q · filed 2016-03-31 | $100.76M derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-11-30 | $30.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-08 | $51.77M 10-Q · filed 2016-01-08 | $76.27M derived: sum of 3 quarters · filed 2016-07-29 | $91.23M derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-08-31 | $21.77M 10-Q · filed 2015-09-30 | $46.26M derived: sum of 2 quarters · filed 2016-07-29 | $61.23M derived: sum of 3 quarters · filed 2016-07-29 | $82.29M derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-05-31 | $24.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $39.47M derived: sum of 2 quarters · filed 2016-07-29 | $60.53M derived: sum of 3 quarters · filed 2016-07-29 | $91.69M 10-K · filed 2016-07-29 |
| 2014-02-28 | $14.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-01 | $36.03M derived: sum of 2 quarters · filed 2015-04-01 | $67.19M 10-Q · filed 2015-04-01 | $93.81M derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-11-30 | $21.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-30 | $52.23M 10-Q · filed 2014-12-30 | $78.84M derived: sum of 3 quarters · filed 2015-07-30 | $90.92M derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-08-31 | $31.16M 10-Q · filed 2014-09-30 | $57.78M derived: sum of 2 quarters · filed 2015-07-30 | $69.86M derived: sum of 3 quarters · filed 2015-07-30 | $85.09M derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-05-31 | $26.62M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30 | $38.69M derived: sum of 2 quarters · filed 2015-07-30 | $53.93M derived: sum of 3 quarters · filed 2015-07-30 | $82.78M 10-K · filed 2015-07-30 |
| 2013-02-28 | $12.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-04 | $27.31M derived: sum of 2 quarters · filed 2014-04-04 | $56.16M 10-Q · filed 2014-04-04 | $73.51M derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-11-30 | $15.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-09 | $44.08M 10-Q · filed 2014-01-09 | $61.43M derived: sum of 3 quarters · filed 2014-07-30 | $77.51M derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-08-31 | $28.85M 10-Q · filed 2013-09-30 | $46.20M derived: sum of 2 quarters · filed 2014-07-30 | $62.28M derived: sum of 3 quarters · filed 2014-07-30 | $75.32M derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-05-31 | $17.35M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | $33.43M derived: sum of 2 quarters · filed 2014-07-30 | $46.47M derived: sum of 3 quarters · filed 2014-07-30 | $71.63M 10-K · filed 2014-07-30 |
| 2012-02-29 | $16.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-28 | $29.12M derived: sum of 2 quarters · filed 2013-03-28 | $54.28M 10-Q · filed 2013-03-28 | $69.90M derived: sum of 4 quarters · filed 2013-07-30 |
| 2011-11-30 | $13.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-28 | $38.20M 10-Q · filed 2012-12-28 | $53.82M derived: sum of 3 quarters · filed 2013-07-30 | $68.17M derived: sum of 4 quarters · filed 2013-07-30 |
| 2011-08-31 | $25.16M 10-Q · filed 2012-09-28 | $40.78M derived: sum of 2 quarters · filed 2013-07-30 | $55.13M derived: sum of 3 quarters · filed 2013-07-30 | $74.53M derived: sum of 4 quarters · filed 2013-07-30 |
| 2011-05-31 | $15.62M derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-30 | $29.97M derived: sum of 2 quarters · filed 2013-07-30 | $49.37M derived: sum of 3 quarters · filed 2013-07-30 | $60.31M 10-K · filed 2013-07-30 |
| 2011-02-28 | $14.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-30 | $33.75M derived: sum of 2 quarters · filed 2012-03-30 | $44.70M 10-Q · filed 2012-03-30 | |
| 2010-11-30 | $19.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-30 | $30.34M 10-Q · filed 2011-12-30 | ||
| 2010-08-31 | $10.95M 10-Q · filed 2011-09-30 | |||
| 2010-05-31 | $0.00 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |